Kymera Therapeutics Presents New Preclinical Data for KT-579 Kymera Therapeutics, Inc. announced the presentation of new preclinical data for KT-579, a first-in-class, oral IRF5 degrader, …
Zenas BioPharma Announces Positive Results from Phase 2 MoonStone Trial Zenas BioPharma, Inc. announced positive results from the Phase 2 …
Bird Flu Strain H9N2: A Potential Pandemic Threat A 'minor' bird flu strain, H9N2, has shown potential to spark a human pandemic, despite …
Banks' Stampede for Deposits to Intensify The competition for deposits among local commercial banks is expected to escalate, as the centra…
Isuzu FA Trophy Second Round Proper Draw Confirmed The draw for the Isuzu FA Trophy Second Round Proper has been announced, featuring 40 m…
The Turkish Experience: A Language Barrier In traditional Botswana, a Setswana maxim states: “Go tsamaya ke go bona (the exper…
CTD-ILD Burden on Older Patients and Women The incidence and prevalence of Connective Tissue Diseases with Interstitial Lung Disease (CTD-…
Community Pharmacies and BioPharma: Advancing Whole-Patient Care Together The healthcare landscape has become increasingly complex, with a…
OPPO and Ballet Philippines Partnership OPPO has announced a partnership with Ballet Philippines to promote Filipino artistry, coinciding …
Government Reforms Environmental Regulations to Boost Housebuilding The government has announced reforms to environmental regulations in a…
Utah's Olympic Organizers in NYC Leaders of Utah's 2034 Winter Games are in New York City to show support for American athletes competing …